These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11781259)

  • 1. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia.
    Adinolfi E; Melchiorri L; Falzoni S; Chiozzi P; Morelli A; Tieghi A; Cuneo A; Castoldi G; Di Virgilio F; Baricordi OR
    Blood; 2002 Jan; 99(2):706-8. PubMed ID: 11781259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases.
    Gu B; Bendall LJ; Wiley JS
    Blood; 1998 Aug; 92(3):946-51. PubMed ID: 9680363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes.
    Cabrini G; Falzoni S; Forchap SL; Pellegatti P; Balboni A; Agostini P; Cuneo A; Castoldi G; Baricordi OR; Di Virgilio F
    J Immunol; 2005 Jul; 175(1):82-9. PubMed ID: 15972634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2Y(11) receptor expression by human lymphocytes: evidence for two cAMP-linked purinoceptors.
    Conigrave AD; Fernando KC; Gu B; Tasevski V; Zhang W; Luttrell BM; Wiley JS
    Eur J Pharmacol; 2001 Aug; 426(3):157-63. PubMed ID: 11527539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antibiotic polymyxin B modulates P2X7 receptor function.
    Ferrari D; Pizzirani C; Adinolfi E; Forchap S; Sitta B; Turchet L; Falzoni S; Minelli M; Baricordi R; Di Virgilio F
    J Immunol; 2004 Oct; 173(7):4652-60. PubMed ID: 15383600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel.
    Wiley JS; Gargett CE; Zhang W; Snook MB; Jamieson GP
    Am J Physiol; 1998 Nov; 275(5):C1224-31. PubMed ID: 9814970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death.
    Salaro E; Rambaldi A; Falzoni S; Amoroso FS; Franceschini A; Sarti AC; Bonora M; Cavazzini F; Rigolin GM; Ciccone M; Audrito V; Deaglio S; Pelegrin P; Pinton P; Cuneo A; Di Virgilio F
    Sci Rep; 2016 May; 6():26280. PubMed ID: 27221966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The P2X7 receptor of CLL lymphocytes-a molecule with a split personality.
    Di Virgilio F; Wiley JS
    Lancet; 2002 Dec; 360(9349):1898-9. PubMed ID: 12493250
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of antigen receptor-dependent Ca(2+) signals and NF-AT activation by P2X7 receptors in human B lymphocytes.
    Pippel A; Beßler B; Klapperstück M; Markwardt F
    Cell Calcium; 2015 Apr; 57(4):275-89. PubMed ID: 25678443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome.
    Nückel H; Frey UH; Dürig J; Dührsen U; Siffert W
    Eur J Haematol; 2004 Apr; 72(4):259-63. PubMed ID: 15089763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study.
    Wiley JS; Dao-Ung LP; Gu BJ; Sluyter R; Shemon AN; Li C; Taper J; Gallo J; Manoharan A
    Lancet; 2002 Mar; 359(9312):1114-9. PubMed ID: 11943260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.
    Arvaniti E; Ntoufa S; Papakonstantinou N; Touloumenidou T; Laoutaris N; Anagnostopoulos A; Lamnissou K; Caligaris-Cappio F; Stamatopoulos K; Ghia P; Muzio M; Belessi C
    Haematologica; 2011 Nov; 96(11):1644-52. PubMed ID: 21750087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes.
    Narcisse L; Scemes E; Zhao Y; Lee SC; Brosnan CF
    Glia; 2005 Jan; 49(2):245-58. PubMed ID: 15472991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rottlerin inhibits P2X(7) receptor-stimulated phospholipase D activity in chronic lymphocytic leukaemia B-lymphocytes.
    Shemon AN; Sluyter R; Wiley JS
    Immunol Cell Biol; 2007 Jan; 85(1):68-72. PubMed ID: 17130901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells.
    Takenouchi T; Sato M; Kitani H
    J Neurochem; 2007 Sep; 102(5):1518-1532. PubMed ID: 17437542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of P2X(7) purinoceptors on human lymphocytes and monocytes: evidence for nonfunctional P2X(7) receptors.
    Gu BJ; Zhang WY; Bendall LJ; Chessell IP; Buell GN; Wiley JS
    Am J Physiol Cell Physiol; 2000 Oct; 279(4):C1189-97. PubMed ID: 11003599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
    Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
    Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective apoptosis due to Bcl-2 overexpression may explain why B-CLL cells accumulate in G0.
    Gottardi D; Alfarano A; De Leo AM; Stacchini A; Bergui L; Caligaris-Cappio F
    Curr Top Microbiol Immunol; 1995; 194():307-12. PubMed ID: 7895503
    [No Abstract]   [Full Text] [Related]  

  • 19. The Pro-451 to Leu polymorphism within the C-terminal tail of P2X7 receptor impairs cell death but not phospholipase D activation in murine thymocytes.
    Le Stunff H; Auger R; Kanellopoulos J; Raymond MN
    J Biol Chem; 2004 Apr; 279(17):16918-26. PubMed ID: 14761980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis.
    Cragg MS; Chan HT; Fox MD; Tutt A; Smith A; Oscier DG; Hamblin TJ; Glennie MJ
    Blood; 2002 Nov; 100(9):3068-76. PubMed ID: 12384401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.